Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19Cardiac Conditions?
dc.contributor.author | Dwivedi, S | en_US |
dc.contributor.author | Sharma, V | en_US |
dc.contributor.author | Patil, CR. | en_US |
dc.date.accessioned | 2023-06-17T07:12:09Z | |
dc.date.available | 2023-06-17T07:12:09Z | |
dc.date.issued | 2022-03 | |
dc.identifier.affiliations | Department of Cardiology, National Heart Institute, Community Center, East of Kailash, New Delhi, Delhi, India | en_US |
dc.identifier.affiliations | Department of Cardiology, National Heart Institute, Community Center, East of Kailash, New Delhi, Delhi, India | en_US |
dc.identifier.affiliations | Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, Pushpvihar, New Delhi, India. | en_US |
dc.identifier.citation | Dwivedi S, Sharma V, Patil CR. . Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19Cardiac Conditions?. Journal of Pharmacology and Pharmacotherapeutics. 2022 Mar; 13(1): 95–96 | en_US |
dc.identifier.issn | 0976-500X | |
dc.identifier.issn | 0976-5018 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/216039 | |
dc.language | en | en_US |
dc.publisher | SAGE Publications | en_US |
dc.relation.issuenumber | 1 | en_US |
dc.relation.volume | 13 | en_US |
dc.source.uri | https://doi.org/10.1177/0976500X221080202 | en_US |
dc.title | Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19Cardiac Conditions? | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1